Literature DB >> 32188995

Possible New Symptoms of Tobacco Withdrawal III: Reduced Positive Affect-A Review and Meta-analysis.

Elias M Klemperer1,2, John R Hughes1,2, Catherine E Peasley-Miklus1, Peter W Callas3, Jessica W Cook4, Joanna M Streck1,2,5, Nicolas E Morley1.   

Abstract

INTRODUCTION: Most descriptions of tobacco withdrawal have not changed in >30 years despite new research. This meta-analysis tested whether abstinence leads to decreased positive affect (PA) because abstinence-induced symptom changes are a core feature of the tobacco withdrawal syndrome. In addition, we examined whether reduced PA was due to withdrawal (ie, temporary decrease in a "U-shaped" curve) or offset (ie, return to baseline) effect.
METHODS: Our main inclusion criterion was a prospective within-participant test of change in PA during abstinence conditions among people who smoke cigarettes daily who were not using a cessation medication. Our search of PubMed, PsycINFO, and personal libraries yielded a total of 32 tests with 2054 participants.
RESULTS: There was a medium effect size indicating an overall decrease in PA following abstinence from cigarettes (Cohen's d = -0.40, 95% CI = -0.30 to -0.49). There was large heterogeneity (I2 = 70.7%). Most (79%) of the 24 trials that conducted significance tests reported that reduction in PA was significant. Seven tests were adequately designed to detect a withdrawal versus offset effect. Over half (57%) displayed a U-shaped curve for abstinence-induced change in PA indicative of a withdrawal symptom rather than offset effect.
CONCLUSIONS: Abstinence from cigarettes is associated with a decrease in PA. Whether low PA should be added to withdrawal measures and diagnostic criteria requires replication of the time-course of change in PA and tests of whether abstinence-induced changes in PA and negative affect occur independently. IMPLICATIONS: Though there was substantial heterogeneity among trials, our findings suggest that (1) abstinence from cigarettes decreases positive affect and (2) this decrease may represent a withdrawal effect (vs. an offset effect). However, it is unclear whether abstinence-induced losses in positive affect are independent from increased negative affect.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2021        PMID: 32188995      PMCID: PMC7822099          DOI: 10.1093/ntr/ntaa044

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  62 in total

Review 1.  Drug addiction, dysregulation of reward, and allostasis.

Authors:  G F Koob; M Le Moal
Journal:  Neuropsychopharmacology       Date:  2001-02       Impact factor: 7.853

2.  Hedonic capacity, cigarette craving, and diminished positive mood.

Authors:  Jessica Werth Cook; Bonnie Spring; Dennis McChargue; Donald Hedeker
Journal:  Nicotine Tob Res       Date:  2004-02       Impact factor: 4.244

3.  Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette Dependence.

Authors:  Karl Fagerström
Journal:  Nicotine Tob Res       Date:  2011-10-24       Impact factor: 4.244

4.  A quantitative analysis of subjective, cognitive, and physiological manifestations of the acute tobacco abstinence syndrome.

Authors:  Adam M Leventhal; Andrew J Waters; Eric T Moolchan; Stephen J Heishman; Wallace B Pickworth
Journal:  Addict Behav       Date:  2010-08-10       Impact factor: 3.913

5.  Effect of nicotine on the tobacco withdrawal syndrome.

Authors:  J R Hughes; D K Hatsukami; R W Pickens; D Krahn; S Malin; A Luknic
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  Psychological mediators of bupropion sustained-release treatment for smoking cessation.

Authors:  Danielle E McCarthy; Thomas M Piasecki; Daniel L Lawrence; Douglas E Jorenby; Saul Shiffman; Timothy B Baker
Journal:  Addiction       Date:  2008-09       Impact factor: 6.526

7.  Randomized controlled trial of behavioral activation smoking cessation treatment for smokers with elevated depressive symptoms.

Authors:  Laura MacPherson; Matthew T Tull; Alexis K Matusiewicz; Samantha Rodman; David R Strong; Christopher W Kahler; Derek R Hopko; Michael J Zvolensky; Richard A Brown; C W Lejuez
Journal:  J Consult Clin Psychol       Date:  2010-02

8.  Prospective examination of effects of smoking abstinence on cortisol and withdrawal symptoms as predictors of early smoking relapse.

Authors:  Mustafa al'Absi; Dorothy Hatsukami; Gary L Davis; Lorentz E Wittmers
Journal:  Drug Alcohol Depend       Date:  2004-03-08       Impact factor: 4.492

9.  Smoking abstinence symptoms across 67 days compared with randomized controls-Moderation by nicotine replacement therapy, bupropion, and negative-affect traits.

Authors:  David G Gilbert; Norka E Rabinovich; Elizabeth A Gilbert-Matuskowitz; Keith P Klein; Michele L Pergadia
Journal:  Exp Clin Psychopharmacol       Date:  2019-03-28       Impact factor: 3.492

10.  Behavioral activation for smoking cessation and mood management following a cardiac event: results of a pilot randomized controlled trial.

Authors:  Andrew M Busch; Erin M Tooley; Shira Dunsiger; Elizabeth A Chattillion; John Fani Srour; Sherry L Pagoto; Christopher W Kahler; Belinda Borrelli
Journal:  BMC Public Health       Date:  2017-04-17       Impact factor: 3.295

View more
  2 in total

1.  Feature-Level Analysis of a Smoking Cessation Smartphone App Based on a Positive Psychology Approach: Prospective Observational Study.

Authors:  Bettina B Hoepper; Kaitlyn R Siegel; Hannah A Carlon; Christopher W Kahler; Elyse R Park; Steven Trevor Taylor; Hazel V Simpson; Susanne S Hoeppner
Journal:  JMIR Form Res       Date:  2022-07-28

2.  Anhedonia in tobacco withdrawal among African-American smokers.

Authors:  Madalyn M Liautaud; Afton Kechter; Mariel S Bello; Casey R Guillot; Jason A Oliver; Devin E Banks; Lina M D'Orazio; Adam M Leventhal
Journal:  Exp Clin Psychopharmacol       Date:  2021-06-10       Impact factor: 3.492

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.